AS 2567-2002

1 - AS 2567-2002 LAMINAR FLOW CYTOTOXIC DRUG SAFETY CABINETS
4 - PREFACE
5 - CONTENTS
6 - FOREWORD
7 - 1 SCOPE
7 - 2 REFERENCED DOCUMENTS
8 - 3 GENERAL REQUIREMENTS
9 - 4 CONSTRUCTION REQUIREMENTS
9 - 4.1 Outer shell
9 - 4.2 Work zone
9 - 4.2.1 General
9 - 4.2.2 Viewing window
10 - 4.2.3 Work access opening
10 - 4.2.4 Testing cover
10 - 4.2.5 Work zone illumination
10 - 4.2.6 Work floor
10 - 4.2.7 Additional requirements
13 - 4.2.8 Sump
13 - 4.2.9 Grilles
14 - 4.2.10 Knee space
14 - 4.3 Filters and filter installations
14 - 4.3.1 General
14 - 4.3.2 Prefilters
14 - 4.3.3 HEPA filters
15 - 4.3.4 Activated carbon filters
15 - 4.4 Blowers and alarm systems
15 - 4.4.1 Blowers
15 - 4.4.2 Blower alarm systems
16 - 4.5 Access panels
16 - 4.6 Electrical services
16 - 4.7 Germicidal ultraviolet lamps
16 - 4.8 Post-use overrun control
16 - 5 PERFORMANCE REQUIREMENTS
16 - 5.1 General
17 - 5.2 Critical for cabinet functions
17 - 5.2.1 Filter installation integrity
17 - 5.2.2 Air barrier containment
17 - 5.2.3 Work zone integrity
17 - 5.2.4 Air velocity and uniformity in the work zone
17 - 5.2.5 Alarm operational adjustment
17 - 5.3 Other requirements
17 - 5.3.1 Sound level
18 - 5.3.2 Lighting
18 - 5.3.3 Vibration
18 - 6 MARKING
19 - APPENDIX A - ERGONOMICS
19 - A1 GENERAL
19 - A2 CONSIDERATION OF ERGONOMICS FOR SAFETY CABINETS AND ISOLATORS
19 - A2.1 General
20 - A2.2 Design
20 - A2.3 Purchase and use

Specifies requirements for open-fronted laminar flow cytotoxic drug safety cabinets which are intended to provide protection for personnel, the environment, and cytotoxic drug products

This Standard specifies requirements for open-fronted laminar flow cytotoxic drug safety cabinets which are intended to provide protection for personnel, the environment, and cytotoxic drug products. These cabinets may also find wider application for handling other hazardous drugs and materials (see AS 2639). They are primarily designed to contain aerosols, and are not intended to provide complete protection against particles which may be ejected during procedures such as tablet crushing and grinding. This Standard should be read in conjunction with AS 2639 which describes recommended practices for installation and use of these cabinets. NOTE: Ergonomic considerations for the design and use of cytotoxic drug safety cabinets are addressed in Appendix A.

First published as AS 2567-1982.
Second edition 1994.
Third edition 2002.